Susquehanna International Group’s BioCardia, Inc. Warrant BCDAW Stock Holding History

Susquehanna International Group’s Portfolio BCDAW Stock Details BCDAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-26,827	Closed	-$341	–	13381
2024 Q2	$341	Buy	+26,827	New	+$534	﹤0.01%	11891
2023 Q4	–	Sell	-14,287	Closed	-$2.67K	–	13530
2023 Q3	$2.67K	Buy	+14,287	New	+$7.43K	﹤0.01%	11829
2021 Q2	–	Sell	-12,188	Closed	-$17K	–	13423
2021 Q1	$17K	Buy	12,188 +1,675	+16%	+$2.58K	﹤0.01%	12147
2020 Q4	$14K	Buy	+10,513	New	+$13K	﹤0.01%	10905

Susquehanna International Group's BCDAW Position: Q3 2024 in Review

Susquehanna International Group sold out of BioCardia, Inc. Warrant (BCDAW) in Q3 2024, closing a stake of 26,827 shares — an estimated $341 sold.

Susquehanna International Group first reported a position in BCDAW in Q4 2020 and held it in 4 quarters. The position peaked at $17K in Q1 2021. 0 funds tracked by Wall St. Rank hold BCDAW as of Q3 2024.

Susquehanna International Group reported no remaining BioCardia, Inc. Warrant position as of Q3 2024 after selling out during the quarter.
Susquehanna International Group sold 26,827 BioCardia, Inc. Warrant shares in Q3 2024, an estimated $341.
Susquehanna International Group first reported a position in BioCardia, Inc. Warrant in Q4 2020 and held it in 4 quarters.
Susquehanna International Group's BioCardia, Inc. Warrant position peaked at $17K in Q1 2021.
0 funds tracked by Wall St. Rank held BioCardia, Inc. Warrant as of Q3 2024.

Based on Susquehanna International Group's 13F filing for Q3 2024, filed 14 Nov 2024.